Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-127304
Filing Date
2023-04-28
Accepted
2023-04-28 16:42:05
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d358125ddefa14a.htm DEFA14A 12151
2 GRAPHIC g358125g00m17.jpg GRAPHIC 282863
3 GRAPHIC g358125g00m18.jpg GRAPHIC 182593
  Complete submission text file 0001193125-23-127304.txt   654527
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36274 | Film No.: 23867419
SIC: 2834 Pharmaceutical Preparations